Accumulation of inositol phosphates in low-passage human meningioma cells following treatment with epidermal growth factor
- 1 May 1994
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 80 (5) , 890-896
- https://doi.org/10.3171/jns.1994.80.5.0890
Abstract
In order to elucidate some of the signal transduction processes in human meningioma cells, the authors studied the effect of epidermal growth factor (EGF) and bromocriptine on inositol phospholipid hydrolysis, using low-passage human meningioma cells in culture. Epidermal growth factor is a well-studied mitogenic factor for meningioma cells, whereas bromocriptine is known to have an inhibitory effect on meningioma cell proliferation. The addition of EGF to meningioma cells caused stimulation of inositol phosphate accumulation in a dose-dependent manner at 60 minutes posttreatment, with the maximum effect (120% to 167% of control) achieved at a concentration of 10 ng/ml. Extraction of separate inositol phosphates accumulation in a dose-dependent manner at 60 minutes posttreatment, with the maximum effect (120% to 167% of control) achieved at a concentration of 10 ng/ml. Extraction of separate inositol phosphates revealed that inositol monophosphate (IP1) and inositol bisphosphate (IP2), but not inositol trisphosphate (IP3), accounted for the increase at 60 minutes. Kinetic analysis of EGF-stimulated inositol phospholipid hydrolysis showed that a sharp and transient increase in IP3 from 5 to 12 minutes post-EGF and a transient but more gradual increase in IP2 from 2 to 12 minutes post-EGF were followed by a gradual and steady increase in IP1, which was significantly greater than control after 5 minutes. On the other hand, long-term studies showed a down-regulation of inositol phosphate accumulation (a 64% decrease vs. control) after 7 days of treatment with EGF (10 ng/ml). Bromocriptine (5 microM) exhibited no significant effect on inositol phosphate accumulation at 60 minutes in four of five meningiomas studied. However, of two meningiomas studied with bromocriptine in combination with EGF, both showed a significant additive increase in inositol phosphate accumulation compared to those treated with EGF alone. The results suggest a close involvement of inositol phospholipid turnover in human meningioma cells in response to mitogenic stimulation by EGF.Keywords
This publication has 36 references indexed in Scilit:
- Autocrine control of human meningioma proliferation: Secretion of platelet-derived growth-factor-like moleculesInternational Journal of Cancer, 1991
- Immunohistochemical Demonstration of Protein Kinase C Isozymes in Human Brain TumorsNeurosurgery, 1991
- Hormonal dependency of cerebral meningiomasJournal of Neurosurgery, 1990
- Epidermal growth factor and platelet-derived growth factor promote translocation of phospholipase C-γ from cytosol to membraneFEBS Letters, 1990
- Effect of Phospholipase C-γ Overexpression on PDGF-induced Second Messengers and MitogenesisScience, 1990
- Fibroblast growth factor stimulates protein kinase C in quiescent 3T3 cells without Ca2+ mobilization or inositol phosphate accumulationJournal of Cellular Physiology, 1990
- Epidermal growth factor‐induced increases in inositol trisphosphates, inositol tetrakisphosphates, and cytosolic Ca2+ in a human hepatocellular carcinoma‐derived cell lineFEBS Letters, 1988
- GROWTH FACTOR RECEPTOR TYROSINE KINASESAnnual Review of Biochemistry, 1988
- Inositol phospholipid hydrolysis in cultured astrocytes and oligodendrocytesLife Sciences, 1987
- Allosteric regulation of the epidermal growth factor receptor kinase.The Journal of cell biology, 1986